The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global HIV-AIDS Testing Market Research Report 2025

Global HIV-AIDS Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1903956

No of Pages : 108

Ask Your Query

Synopsis

HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease.

HIV-AIDS most often spread through unprotected sex with HIV infected person. In addition, HIV-AIDS can also be spread from infected mother to child during pregnancy, infected blood and sharing needles with someone who has HIV-AIDS. Some of the symptoms of HIV include slight fever, swollen glands, muscle aches, headaches and fatigue.

The global HIV-AIDS Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for HIV-AIDS Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for HIV-AIDS Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for HIV-AIDS Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of HIV-AIDS Testing include Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Diamedix and DiaSorin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for HIV-AIDS Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV-AIDS Testing.

Report Scope

The HIV-AIDS Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV-AIDS Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HIV-AIDS Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Lonza
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio

Segment by Type

  • Kits and Reagents
  • Instruments
  • Others

Segment by Application

  • Hospitals
  • Private Diagnostics Laboratories
  • Academic and Research Institutes
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV-AIDS Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV-AIDS Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kits and Reagents
1.2.3 Instruments
1.2.4 Others
1.3 Market by Application
1.3.1 Global HIV-AIDS Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Private Diagnostics Laboratories
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV-AIDS Testing Market Perspective (2019-2030)
2.2 HIV-AIDS Testing Growth Trends by Region
2.2.1 Global HIV-AIDS Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HIV-AIDS Testing Historic Market Size by Region (2019-2024)
2.2.3 HIV-AIDS Testing Forecasted Market Size by Region (2025-2030)
2.3 HIV-AIDS Testing Market Dynamics
2.3.1 HIV-AIDS Testing Industry Trends
2.3.2 HIV-AIDS Testing Market Drivers
2.3.3 HIV-AIDS Testing Market Challenges
2.3.4 HIV-AIDS Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV-AIDS Testing Players by Revenue
3.1.1 Global Top HIV-AIDS Testing Players by Revenue (2019-2024)
3.1.2 Global HIV-AIDS Testing Revenue Market Share by Players (2019-2024)
3.2 Global HIV-AIDS Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV-AIDS Testing Revenue
3.4 Global HIV-AIDS Testing Market Concentration Ratio
3.4.1 Global HIV-AIDS Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV-AIDS Testing Revenue in 2023
3.5 HIV-AIDS Testing Key Players Head office and Area Served
3.6 Key Players HIV-AIDS Testing Product Solution and Service
3.7 Date of Enter into HIV-AIDS Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV-AIDS Testing Breakdown Data by Type
4.1 Global HIV-AIDS Testing Historic Market Size by Type (2019-2024)
4.2 Global HIV-AIDS Testing Forecasted Market Size by Type (2025-2030)
5 HIV-AIDS Testing Breakdown Data by Application
5.1 Global HIV-AIDS Testing Historic Market Size by Application (2019-2024)
5.2 Global HIV-AIDS Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HIV-AIDS Testing Market Size (2019-2030)
6.2 North America HIV-AIDS Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HIV-AIDS Testing Market Size by Country (2019-2024)
6.4 North America HIV-AIDS Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV-AIDS Testing Market Size (2019-2030)
7.2 Europe HIV-AIDS Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HIV-AIDS Testing Market Size by Country (2019-2024)
7.4 Europe HIV-AIDS Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV-AIDS Testing Market Size (2019-2030)
8.2 Asia-Pacific HIV-AIDS Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HIV-AIDS Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific HIV-AIDS Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV-AIDS Testing Market Size (2019-2030)
9.2 Latin America HIV-AIDS Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HIV-AIDS Testing Market Size by Country (2019-2024)
9.4 Latin America HIV-AIDS Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV-AIDS Testing Market Size (2019-2030)
10.2 Middle East & Africa HIV-AIDS Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HIV-AIDS Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa HIV-AIDS Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott HIV-AIDS Testing Introduction
11.1.4 Abbott Revenue in HIV-AIDS Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Detail
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix HIV-AIDS Testing Introduction
11.2.4 Affymetrix Revenue in HIV-AIDS Testing Business (2019-2024)
11.2.5 Affymetrix Recent Development
11.3 Beckman Coulter/Danaher
11.3.1 Beckman Coulter/Danaher Company Detail
11.3.2 Beckman Coulter/Danaher Business Overview
11.3.3 Beckman Coulter/Danaher HIV-AIDS Testing Introduction
11.3.4 Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2019-2024)
11.3.5 Beckman Coulter/Danaher Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Detail
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson HIV-AIDS Testing Introduction
11.4.4 Becton Dickinson Revenue in HIV-AIDS Testing Business (2019-2024)
11.4.5 Becton Dickinson Recent Development
11.5 bioMerieux
11.5.1 bioMerieux Company Detail
11.5.2 bioMerieux Business Overview
11.5.3 bioMerieux HIV-AIDS Testing Introduction
11.5.4 bioMerieux Revenue in HIV-AIDS Testing Business (2019-2024)
11.5.5 bioMerieux Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad HIV-AIDS Testing Introduction
11.6.4 Bio-Rad Revenue in HIV-AIDS Testing Business (2019-2024)
11.6.5 Bio-Rad Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Detail
11.7.2 Cepheid Business Overview
11.7.3 Cepheid HIV-AIDS Testing Introduction
11.7.4 Cepheid Revenue in HIV-AIDS Testing Business (2019-2024)
11.7.5 Cepheid Recent Development
11.8 Diamedix
11.8.1 Diamedix Company Detail
11.8.2 Diamedix Business Overview
11.8.3 Diamedix HIV-AIDS Testing Introduction
11.8.4 Diamedix Revenue in HIV-AIDS Testing Business (2019-2024)
11.8.5 Diamedix Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Detail
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin HIV-AIDS Testing Introduction
11.9.4 DiaSorin Revenue in HIV-AIDS Testing Business (2019-2024)
11.9.5 DiaSorin Recent Development
11.10 Eiken Chemical
11.10.1 Eiken Chemical Company Detail
11.10.2 Eiken Chemical Business Overview
11.10.3 Eiken Chemical HIV-AIDS Testing Introduction
11.10.4 Eiken Chemical Revenue in HIV-AIDS Testing Business (2019-2024)
11.10.5 Eiken Chemical Recent Development
11.11 Elitech Group
11.11.1 Elitech Group Company Detail
11.11.2 Elitech Group Business Overview
11.11.3 Elitech Group HIV-AIDS Testing Introduction
11.11.4 Elitech Group Revenue in HIV-AIDS Testing Business (2019-2024)
11.11.5 Elitech Group Recent Development
11.12 Enzo Biochem
11.12.1 Enzo Biochem Company Detail
11.12.2 Enzo Biochem Business Overview
11.12.3 Enzo Biochem HIV-AIDS Testing Introduction
11.12.4 Enzo Biochem Revenue in HIV-AIDS Testing Business (2019-2024)
11.12.5 Enzo Biochem Recent Development
11.13 Fujirebio
11.13.1 Fujirebio Company Detail
11.13.2 Fujirebio Business Overview
11.13.3 Fujirebio HIV-AIDS Testing Introduction
11.13.4 Fujirebio Revenue in HIV-AIDS Testing Business (2019-2024)
11.13.5 Fujirebio Recent Development
11.14 Lonza
11.14.1 Lonza Company Detail
11.14.2 Lonza Business Overview
11.14.3 Lonza HIV-AIDS Testing Introduction
11.14.4 Lonza Revenue in HIV-AIDS Testing Business (2019-2024)
11.14.5 Lonza Recent Development
11.15 Roche
11.15.1 Roche Company Detail
11.15.2 Roche Business Overview
11.15.3 Roche HIV-AIDS Testing Introduction
11.15.4 Roche Revenue in HIV-AIDS Testing Business (2019-2024)
11.15.5 Roche Recent Development
11.16 Scienion
11.16.1 Scienion Company Detail
11.16.2 Scienion Business Overview
11.16.3 Scienion HIV-AIDS Testing Introduction
11.16.4 Scienion Revenue in HIV-AIDS Testing Business (2019-2024)
11.16.5 Scienion Recent Development
11.17 Sequenom
11.17.1 Sequenom Company Detail
11.17.2 Sequenom Business Overview
11.17.3 Sequenom HIV-AIDS Testing Introduction
11.17.4 Sequenom Revenue in HIV-AIDS Testing Business (2019-2024)
11.17.5 Sequenom Recent Development
11.18 SeraCare
11.18.1 SeraCare Company Detail
11.18.2 SeraCare Business Overview
11.18.3 SeraCare HIV-AIDS Testing Introduction
11.18.4 SeraCare Revenue in HIV-AIDS Testing Business (2019-2024)
11.18.5 SeraCare Recent Development
11.19 Siemens
11.19.1 Siemens Company Detail
11.19.2 Siemens Business Overview
11.19.3 Siemens HIV-AIDS Testing Introduction
11.19.4 Siemens Revenue in HIV-AIDS Testing Business (2019-2024)
11.19.5 Siemens Recent Development
11.20 Takara Bio
11.20.1 Takara Bio Company Detail
11.20.2 Takara Bio Business Overview
11.20.3 Takara Bio HIV-AIDS Testing Introduction
11.20.4 Takara Bio Revenue in HIV-AIDS Testing Business (2019-2024)
11.20.5 Takara Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock